Pharmaco Vigilance and Adverse Drug Reaction Reporting
Abstract
Pharmaco vigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug – related problem. Various types of Adverse Drug Reactions are described, its mechanisms explained and the importance of recognizing it is mentioned. Training programmes to help detect ADRs are needed. The method of providing a proper ADR report is provided.
Monitoring of adverse drug reactions is an ongoing, ceaseless and continuing process. Given the limitation of clinical trials in identifying rare and delayed ADR‘s, and the need for comprehensive safety profiles, the importance of reporting ADR‘s cannot be over-emphasized. Given the limitation of clinical trials in identifying rare and delayed ADR’s, and the need for comprehensive safety profiles, the importance of reporting ADR‘s cannot be over-emphasized. Most of the time the ADRs mentioned in formularies is based on Western experience. ADR‘s in Indian population can differ, and it is important that we know ADR’s in Indian population and this can be known only if the ADR‘s are reported.
When publishing with Kerala Medicial Journal (KMJ), authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Work includes the material submitted for publication and any other related material submitted to KMJ. In the event that KMJ does not publish said work, the author(s) will be so notified and all rights assigned hereunder will revert to the author(s).
The assignment of rights to KMJ includes but is not expressly limited to rights to edit, publish, reproduce, distribute copies, include in indexes or search databases in print, electronic, or other media, whether or not in use at the time of execution of this agreement.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
The author(s) hereby represents and warrants that they are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work based on substantially similar data has been submitted to another publication.
